Energy & Commodities

Francisco Bermea's picture
September: Bad for Stocks, Great for this Investment

The average return for stocks during September is -1%. Here's how to ward off those losses and ink an average +8% gain this month.

by Francisco Bermea | September 08, 2009
Andy Obermueller's picture
Do You Own One of the 10 Most-Hated Stocks On Wall Street?

Investors are placing massive bets against these 10 S&P 500 companies. Make sure you don't own these stocks -- my research is telling me they're about to plummet.

by Andy Obermueller | August 06, 2009
Kyle Hartman's picture
Brokers Ban New Kind of "Dangerous" ETF

If you're one of the millions of Americans who own these leveraged funds, then it's time to get out.  They're coming under fire from financial authorities, and regulators say they're no longer suitable for individual investors.  Don't get caught holding these ETFs.

by Kyle Hartman | July 31, 2009
Meredith Margrave's picture
This Company is Next in Line for Bankruptcy

This widely-held stock runs an outdated business with a shrinking customer base. It's only a matter of time before the company goes belly-up. Make sure you don't get caught holding this stock.

by Meredith Margrave | July 22, 2009
Brad Briggs's picture
Biogen Looks Better Than Ever as a Takeover Target

The company exceeded analyst expectations and posted a +10% increase in revenue. Corporate raider, Carl Icahn, may take advantage of a retiring chairman to put Biogen on the block.

by Brad Briggs | July 16, 2009
Anthony Haddad's picture
Harley Davidson Shares Aren't Going to Win Off the Line

Milwaukee's most notable company failed to meet analyst expectations of a quarter per share instead earning just eight cents a share. Despite short term setbacks, Harley Davidson shares could be a solid addition for long term investors.

by Anthony Haddad | July 16, 2009
Brad Briggs's picture
Johnson & Johnson Still Undervalued After Beating the Street

Johnson & Johnson beat Wall Street with earnings of $1.15 per share today. The world’s largest healthcare company has been buying other firms with new drugs for its product line and is trading at a historically-low valuation.

by Brad Briggs | July 14, 2009
Francisco Bermea's picture
Goldman Sachs Earnings Exceed Expectations

Goldman Sachs reported earnings today and easily surpassed expectations. Many analysts see an upside to Goldman's share and have rated it a "buy". Find out how they shattered their previous earnings record.

by Francisco Bermea | July 14, 2009
Anthony Haddad's picture
The Sectors That Will Lead the Real Recovery

Questions surround the U.S. economy. We take a historical look at recessions and recoveries in hopes of gaining an insight to current market conditions. Find a way to profit from every section of the downturn and recovery.

by Anthony Haddad | July 13, 2009
Anthony Haddad's picture
Consumer Credit Delinquencies Reach All-Time High

The collapse of the housing market and rising unemployment are making it increasingly difficult for consumers to pay their bills. Delinquencies -- payments more than 30 days past due -- are on the rise.

by Anthony Haddad | July 13, 2009